EUDA Health Holdings Ltd (EUDA) - Dilution Analysis

Visualizing historical and potential share dilution over time

Dilution Analysis

High Risk
Significant dilution risk
Last updated: April 28, 2026

Risk Assessment Details

Potential Dilution: 1327.08% of current shares
Recent Dilution: 62.24% (2 years)
Historical Dilution Factor: significant recent dilution
Outstanding Shares
1.9M
Potential Supply
25M
Additional shares possible
Splits
None
Past 2 years

Summary

EUDA currently has 1.87M outstanding shares. with significant dilution risk as 24.8M authorized shares could dilute existing holders by 1327.1%. The company has significantly diluted shareholders by 62.24% over the past 2 years, indicating aggressive capital raising.

Share Structure Timeline

Outstanding Shares
Total Supply

Historical Data Points

Date Event Outstanding Supply
Apr 28, 2026

20-F filing | 1.9M shares outstanding

1.9M 25M
Apr 29, 2025

20-F filing | 37.2M shares outstanding

37M 25M
Oct 18, 2024

F-3 filing: This F-3 filing describes a shelf registration process under which the company may offer and sell securities up to a total dollar amount of $100,000,000 in one or more offerings.

23M 25M
May 09, 2024

20-F filing | 22.9M shares outstanding

23M 25M
Jul 31, 2023

10-Q filing | 24.8M shares outstanding

25M 25M
Jun 28, 2023

10-K filing | 24.8M shares outstanding

25M 25M
Jun 09, 2023

8-K filing: EUDA Health Holdings Limited issued 578,439 ordinary shares to Dr. Kelvin Chen at $1.47 per share and 1,600,000 ordinary shares in the aggregate to certain institutional investors pursuant to amendments to prepaid forward agreements. ($0.85M proceeds)

20M 25M
Dec 23, 2022

S-1 filing: This is an S-1 filing for the resale of ordinary shares, convertible notes, and warrants of EUDA Health Holdings Limited by selling shareholders.

20M 25M
Nov 22, 2022

10-Q filing | 20.2M shares outstanding

20M 7.6M
Nov 14, 2022

8-K filing: 8i Acquisition 2 Corp. entered into a Prepaid Forward Agreement with EUDA Health Limited and an institutional investor (the "Seller") for an equity prepaid forward transaction where the Seller may purchase up to 1,125,000 of 8i's Ordinary Shares.

11M 7.6M
Nov 10, 2022

8-K filing: 8i Acquisition 2 Corp. entered into a Prepaid Forward Agreement with EUDA Health Limited and an institutional investor for an equity prepaid forward transaction involving up to 1,400,000 shares, and terminated the Forward Purchase Agreement with Greentree Financial Group, Inc.

11M 7.6M
Nov 07, 2022

8-K filing: 8i Acquisition 2 Corp. entered into a Forward Share Purchase Agreement with Greentree Financial Group, Inc., where Greentree may elect to sell up to 125,000 ordinary shares to 8i at $10.41 per share, and 8i and the Seller entered into a Waiver Agreement waiving certain conditions to closing of the Share Purchase. ($1.3M proceeds)

11M 7.6M
Aug 29, 2022

10-K filing | 11.1M shares outstanding

11M 7.6M
Jun 10, 2022

8-K filing: 8i Acquisition 2 Corp. amends its Share Purchase Agreement with Euda Health Limited to adjust the initial consideration to $140,000,000, payable in LAX ordinary shares valued at $10.00 per share, with 1,400,000 shares held in escrow for indemnification, and includes potential earnout payments of up to 4,000,000 additional shares based on Purchaser Share Price and EUDA Health's financial performance. ($140.0M proceeds)

11M 7.6M
May 25, 2022

10-Q filing | 11.1M shares outstanding

11M 7.6M
Apr 12, 2022

8-K filing: 8i Acquisition 2 Corp. entered into a Share Purchase Agreement with Euda Health Limited, Watermark Developments Limited, and Kwong Yeow Liew to effect a business combination through the purchase by LAX of all issued and outstanding shares of EUDA Health from the Seller for $550,000,000 payable in Purchaser Shares valued at $10 per share, with a potential for an additional 9,000,000 Purchaser Shares as earnout payments. ($550.0M proceeds)

11M 7.6M
Mar 08, 2022

10-Q filing | 11.1M shares outstanding

11M 7.6M
Dec 22, 2021

10-Q filing | 11.1M shares outstanding

11M 7.6M
Dec 01, 2021

8-K filing: The company consummated its IPO of 7,500,000 units at $10.00 per unit, generating gross proceeds of $75,000,000. The underwriters exercised their option in full, purchasing 1,125,000 additional units, resulting in total gross proceeds of $86,250,000 from the issuance of 8,625,000 units. Simultaneously, the company sold 292,250 units to its Sponsor in a private placement for $2,922,500. ($89.17M proceeds)

N/A 7.6M
Nov 24, 2021

8-K filing: 8i Acquisition 2 Corp. consummated its initial public offering of 7,500,000 units at $10.00 per unit, generating gross proceeds of $75,000,000, and simultaneously closed the underwriter's over-allotment option for 1,125,000 additional units, resulting in total gross proceeds of $86,250,000. Simultaneously with the closing of the IPO, the Company consummated the private placement with Meng Dong (James) Tan, the Company's Chief Executive Officer, of 292,250 units at a price of $10.00 per Private Unit, generating total proceeds of $2,922,500. ($89.17M proceeds)

N/A 7.6M
Nov 09, 2021

S-1/A filing: This is an S-1/A filing for an initial public offering of units, each consisting of one ordinary share, one redeemable warrant, and one right to receive one-tenth (1/10) of an ordinary share, with a proposed offering amount of $75,000,000.

N/A 7.6M
Oct 04, 2021

S-1/A filing: This is an S-1/A filing for an initial public offering of units of 8i Acquisition 2 Corp, each unit consisting of one ordinary share, one redeemable warrant, and one right to receive one-tenth of an ordinary share, with a proposed offering amount of $50,000,000.

N/A 5.1M
Sep 17, 2021

S-1/A filing: This is an S-1/A filing for an initial public offering of units, each consisting of one ordinary share, one redeemable warrant, and one right to receive one-tenth of an ordinary share, with a proposed offering amount of $50,000,000.

N/A 5.1M
Jul 01, 2021

S-1/A filing: 8i Acquisition 2 Corp. is offering 5,000,000 units at $10.00 per unit in an initial public offering, each unit consisting of one ordinary share, one redeemable warrant, and one right to receive one-tenth of an ordinary share. Additionally, Mr. Meng Dong (James) Tan has committed to purchase 219,750 private units at $10.00 per unit.

N/A 5.3M
Jun 16, 2021

S-1/A filing: This is an S-1/A filing for an initial public offering of units, with each unit consisting of one ordinary share, one redeemable warrant, and one right to receive one-tenth of an ordinary share, along with a private placement of units and potential conversion of promissory notes into units.

N/A 5.1M
May 24, 2021

S-1 filing: This is an S-1 filing for an initial public offering of units of 8i Acquisition 2 Corp, a blank check company, with each unit consisting of one ordinary share, one redeemable warrant, and one right to receive one-tenth of an ordinary share, along with a private placement of units to Mr. Meng Dong (James) Tan.

N/A 5.1M
Weekly Research

Get Weekly Super Stonk Alerts

Never miss a squeeze opportunity. Get our weekly analysis of high short interest stocks, AI-discovered gems, and dilution warnings delivered to your inbox.

No spam Unsubscribe anytime